MIRA Pharmaceuticals, Inc. (MIRA) vs Sanofi (SNY)
- MIRA Pharmaceuticals, Inc. MIRA 0.63 −4.55%
- Sanofi SNY 40.61 +0.79%
MIRA Pharmaceuticals, Inc. and Sanofi are both Drug Manufacturers General companies. Sanofi is the larger, with a market value of $96.0B against $27.7M — 3473.1× the size. MIRA Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Sanofi trades at 21.3×. Sanofi has the higher net margin (8.22% vs 0.00%) and the higher return on invested capital (6.58% vs −12,016.1%). Across the 14 metrics below, Sanofi leads on 11 and MIRA Pharmaceuticals, Inc. on 3.
Valuation
Profitability
| Metric | MIRA | SNY | Drug Manufacturers General median |
|---|---|---|---|
| Gross margin | — | 72.78% | 72.77% |
| Operating margin | 0.00% | 18.24% | 18.77% |
| Net margin | 0.00% | 8.22% | 8.27% |
| Free cash flow margin | 0.00% | 25.53% | 17.18% |
| Return on equity | (710.85%) | 5.87% | 5.87% |
| Return on assets | (684.27%) | 3.21% | 2.57% |
| Return on invested capital | (12,016.10%) | 6.58% | 6.11% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack